UniProt ID | COTL1_HUMAN | |
---|---|---|
UniProt AC | Q14019 | |
Protein Name | Coactosin-like protein | |
Gene Name | COTL1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 142 | |
Subcellular Localization | Cytoplasm . Cytoplasm, cytoskeleton . Nucleus . | |
Protein Description | Binds to F-actin in a calcium-independent manner. Has no direct effect on actin depolymerization. Acts as a chaperone for ALOX5 (5LO), influencing both its stability and activity in leukotrienes synthesis.. | |
Protein Sequence | MATKIDKEACRAAYNLVRDDGSAVIWVTFKYDGSTIVPGEQGAEYQHFIQQCTDDVRLFAFVRFTTGDAMSKRSKFALITWIGENVSGLQRAKTGTDKTLVKEVVQNFAKEFVISDRKELEEDFIKSELKKAGGANYDAQTE | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MATKIDKEA ------CCCHHCHHH | 20.01 | 22814378 | |
4 | Acetylation | ----MATKIDKEACR ----CCCHHCHHHHH | 39.09 | 21339330 | |
4 | Ubiquitination | ----MATKIDKEACR ----CCCHHCHHHHH | 39.09 | - | |
4 | Malonylation | ----MATKIDKEACR ----CCCHHCHHHHH | 39.09 | 26320211 | |
7 | 2-Hydroxyisobutyrylation | -MATKIDKEACRAAY -CCCHHCHHHHHHHH | 51.16 | - | |
7 | Acetylation | -MATKIDKEACRAAY -CCCHHCHHHHHHHH | 51.16 | 23749302 | |
7 | Ubiquitination | -MATKIDKEACRAAY -CCCHHCHHHHHHHH | 51.16 | - | |
14 | Phosphorylation | KEACRAAYNLVRDDG HHHHHHHHHHHCCCC | 14.19 | 28152594 | |
57 | Methylation | QQCTDDVRLFAFVRF HHCCCCCEEEEEEEE | 30.96 | - | |
70 | Sulfoxidation | RFTTGDAMSKRSKFA EEECCCHHCHHHHEE | 6.05 | 30846556 | |
71 | Phosphorylation | FTTGDAMSKRSKFAL EECCCHHCHHHHEEE | 27.00 | 29255136 | |
72 | Acetylation | TTGDAMSKRSKFALI ECCCHHCHHHHEEEE | 47.83 | 23236377 | |
72 | Ubiquitination | TTGDAMSKRSKFALI ECCCHHCHHHHEEEE | 47.83 | - | |
72 | 2-Hydroxyisobutyrylation | TTGDAMSKRSKFALI ECCCHHCHHHHEEEE | 47.83 | - | |
72 | Malonylation | TTGDAMSKRSKFALI ECCCHHCHHHHEEEE | 47.83 | 26320211 | |
75 | Acetylation | DAMSKRSKFALITWI CHHCHHHHEEEEEEC | 38.39 | 25953088 | |
98 | Acetylation | RAKTGTDKTLVKEVV HCCCCCCHHHHHHHH | 43.53 | 25953088 | |
98 | Malonylation | RAKTGTDKTLVKEVV HCCCCCCHHHHHHHH | 43.53 | 26320211 | |
98 | Ubiquitination | RAKTGTDKTLVKEVV HCCCCCCHHHHHHHH | 43.53 | - | |
98 | 2-Hydroxyisobutyrylation | RAKTGTDKTLVKEVV HCCCCCCHHHHHHHH | 43.53 | - | |
102 | Succinylation | GTDKTLVKEVVQNFA CCCHHHHHHHHHHHH | 48.15 | 23954790 | |
102 | Ubiquitination | GTDKTLVKEVVQNFA CCCHHHHHHHHHHHH | 48.15 | 19608861 | |
102 | 2-Hydroxyisobutyrylation | GTDKTLVKEVVQNFA CCCHHHHHHHHHHHH | 48.15 | - | |
102 | Acetylation | GTDKTLVKEVVQNFA CCCHHHHHHHHHHHH | 48.15 | 19608861 | |
110 | Ubiquitination | EVVQNFAKEFVISDR HHHHHHHHHHHCCCH | 47.77 | 19608861 | |
110 | Succinylation | EVVQNFAKEFVISDR HHHHHHHHHHHCCCH | 47.77 | 23954790 | |
110 | Acetylation | EVVQNFAKEFVISDR HHHHHHHHHHHCCCH | 47.77 | 19608861 | |
115 | Phosphorylation | FAKEFVISDRKELEE HHHHHHCCCHHHHHH | 26.51 | 16097034 | |
117 | Methylation | KEFVISDRKELEEDF HHHHCCCHHHHHHHH | 27.79 | - | |
118 | Ubiquitination | EFVISDRKELEEDFI HHHCCCHHHHHHHHH | 72.19 | - | |
118 | 2-Hydroxyisobutyrylation | EFVISDRKELEEDFI HHHCCCHHHHHHHHH | 72.19 | - | |
118 | Malonylation | EFVISDRKELEEDFI HHHCCCHHHHHHHHH | 72.19 | 26320211 | |
126 | 2-Hydroxyisobutyrylation | ELEEDFIKSELKKAG HHHHHHHHHHHHHCC | 37.56 | - | |
126 | Succinylation | ELEEDFIKSELKKAG HHHHHHHHHHHHHCC | 37.56 | 23954790 | |
126 | Ubiquitination | ELEEDFIKSELKKAG HHHHHHHHHHHHHCC | 37.56 | 19608861 | |
126 | Sumoylation | ELEEDFIKSELKKAG HHHHHHHHHHHHHCC | 37.56 | 19608861 | |
126 | Sumoylation | ELEEDFIKSELKKAG HHHHHHHHHHHHHCC | 37.56 | - | |
126 | Acetylation | ELEEDFIKSELKKAG HHHHHHHHHHHHHCC | 37.56 | 19608861 | |
127 | Phosphorylation | LEEDFIKSELKKAGG HHHHHHHHHHHHCCC | 43.26 | 28060719 | |
130 | Ubiquitination | DFIKSELKKAGGANY HHHHHHHHHCCCCCC | 36.20 | - | |
130 | Acetylation | DFIKSELKKAGGANY HHHHHHHHHCCCCCC | 36.20 | 23749302 | |
131 | Ubiquitination | FIKSELKKAGGANYD HHHHHHHHCCCCCCC | 65.96 | - | |
137 | Phosphorylation | KKAGGANYDAQTE-- HHCCCCCCCCCCC-- | 16.48 | 28796482 | |
141 | Phosphorylation | GANYDAQTE------ CCCCCCCCC------ | 45.44 | 28985074 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of COTL1_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of COTL1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of COTL1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
LOX5_HUMAN | ALOX5 | physical | 11297527 | |
ACTS_HUMAN | ACTA1 | physical | 11297527 | |
ACTG_HUMAN | ACTG1 | physical | 11297527 | |
ACTB_HUMAN | ACTB | physical | 11583571 | |
LOX5_HUMAN | ALOX5 | physical | 19807693 | |
GDIR1_HUMAN | ARHGDIA | physical | 26344197 | |
COF1_HUMAN | CFL1 | physical | 26344197 | |
CRIP1_HUMAN | CRIP1 | physical | 26344197 | |
DUT_HUMAN | DUT | physical | 26344197 | |
JUPI1_HUMAN | HN1 | physical | 26344197 | |
MDHM_HUMAN | MDH2 | physical | 26344197 | |
PCBP1_HUMAN | PCBP1 | physical | 26344197 | |
SH3L1_HUMAN | SH3BGRL | physical | 26344197 | |
TAGL2_HUMAN | TAGLN2 | physical | 26344197 | |
TIAR_HUMAN | TIAL1 | physical | 26344197 | |
TKT_HUMAN | TKT | physical | 26344197 | |
UBC12_HUMAN | UBE2M | physical | 26344197 | |
LOX5_HUMAN | ALOX5 | physical | 16924104 | |
LOX5_HUMAN | ALOX5 | physical | 19579006 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-102 AND LYS-126, AND MASSSPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Global phosphoproteome analysis on human HepG2 hepatocytes usingreversed-phase diagonal LC."; Gevaert K., Staes A., Van Damme J., De Groot S., Hugelier K.,Demol H., Martens L., Goethals M., Vandekerckhove J.; Proteomics 5:3589-3599(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-115, AND MASSSPECTROMETRY. |